Atherectomy Devices

The U.S. Food and Drug Administration (FDA) cleared Cardiovascular Systems Inc.’s Diamondback 360 60 cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral arterial disease (PAD).

TCT 2013, most innovative, editors choice, newest cardiac technology

The Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics (TCT) 2013 offers many new insights about the latest cardiovascular technologies and treatment techniques. These are my choices for the most innovative new or futur...

diamondback 360, atherectomy

The U.S. Food and Drug Administration (FDA) approved Cardiovascular Systems Inc.’s Diamondback 360 Coronary Orbital Atherectomy System (OAS) for treatment of pa...

Bayer HealthCare announced that the U.S. Food and Drug Administration (FDA) has cleared two new Jetstream atherectomy catheters. The SC (Single Cutter) atherectomy catheter is available in 1.6-mm and 1.85-mm cutting diameters.  The XC (e...

The U.S. Food and Drug Administration (FDA) cleared Cardiovascular Systems Inc.’s Diamondback 360 60 cm Peripheral Orbital Atherectomy Systems (OAS) for the...
Spectranetics Excite ISR Atherectomy Systems Cath Lab Clinical Trial Study
The Spectranetics Corp. announced that the Excite ISR trial achieved the statistical endpoints of the adjunct analysis. The trial evaluates laser ...
AngioDynamics AngioVac Atherectomy Systems Cath Lab Thrombectomy Devices
Instead of making a chest incision for open heart surgery, cardiovascular surgeons can now use a new vacuum-like tool to remove potentially deadly, large clots...
AtheroMed Phoenix Atherectomy System Device Peripheral Artery Disease PAD
AtheroMed, a developer of catheter technologies for treating peripheral artery disease (PAD), received clearance from the U.S. Food and...
Cardiovascular Systems Inc.’s Diamondback 360 60 cm Peripheral Orbital Atherectomy Systems (OAS) are for the treatment of peripheral
AtheroMed's Phoenix Atherectomy System. This system allows physicians to treat peripheral artery disease (PAD) with a low...
The U.S. Food and Drug Administration (FDA) approved Cardiovascular Systems Inc.’s Diamondback 360 Coronary Orbital Atherectomy System...
The FDA-approved Diamondback 360 Coronary Orbital Atherectomy System (OAS) is a treatment for severely calcified coronary...

Articles

The Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics (TCT) 2013 offers many new insights about the latest cardiovascular...
Cardiovascular Systems Inc. (CSI) has presented 30-day results from its ORBIT II study of coronary artery disease. ORBIT II is evaluating the safety and...
January 31, 2013 — Cardiovascular Systems Inc. (CSI) announced CONFIRM study series data presented at the 2013 International Symposium on Endovascular Therapy...
Spectranetics Peripheral Artery Disease Laser Atherectomy
The Spectranetics Corporation announced final results from the PATENT (Photo-Ablation using the TURBO-Booster(R) and Excimer Laser for In-Stent Restenosis...

Video Center

By Dave Fornell The biggest news item from the American College of Cardiology (ACC) 63rd Annual...
1 week 19 hours ago
By Dave Fornell, DAIC editor Data from several cutting-edge device clinical trials will be...
3 weeks 21 hours ago
By Dave Fornell, editor I have watched a trend in medical technology grow from a small ripple a...
4 weeks 15 hours ago
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve image quality, lesion detection and...
CVIS, cardiovascular information system
This webinar reviews multi-ology, multi-site, vendor neutral solutions that transform rigid departmental information silos into fluid, consolidated, information sharing systems. It discusses how to...
Centricity Cardio Enterprise, Cardiac PACS, Cardio PACS, CVIS
February is American Heart Month, the perfect time to evaluate the health of your cardiology IT system. 
Join us Feb. 25, 2-3 p.m. Eastern for a live demonstration on Centricity Cardio Enterprise...

Comparison Charts

Sorry there is no data available